Does ropinirole interact with sertraline (Zoloft), pregabalin (Lyrica), levetiracetam (Keppra), and labetalol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Drug Interactions Between Ropinirole and Zoloft/Lyrica/Keppra/Labetalol

Ropinirole can be safely combined with Keppra (levetiracetam) and Lyrica (pregabalin) without significant pharmacokinetic interactions, but requires caution when combined with Zoloft (sertraline) due to potential serotonergic effects, and careful monitoring when combined with labetalol due to possible additive hypotensive effects.

Ropinirole + Keppra (Levetiracetam)

No clinically significant drug-drug interaction exists. Levetiracetam is predominantly excreted unchanged in urine with negligible metabolism (<2% metabolized), does not bind to plasma proteins, and is neither an inhibitor nor substrate of cytochrome P450 enzymes 1. This pharmacokinetic profile makes interactions with other medications, including ropinirole, highly unlikely.

  • The FDA label explicitly states that levetiracetam shows no pharmacokinetic interactions with multiple drug classes 1
  • Research actually suggests potential therapeutic synergy: levetiracetam may reduce dyskinesias induced by dopamine agonists like ropinirole in Parkinson's disease models 2
  • No dose adjustments needed for either medication

Ropinirole + Lyrica (Pregabalin)

No pharmacokinetic interaction occurs. Pregabalin undergoes negligible metabolism (<2% metabolized), does not bind to plasma proteins, and is unlikely to be involved in significant pharmacokinetic drug interactions 3.

However, monitor for additive CNS effects:

  • The FDA label warns that pregabalin combined with other CNS-active drugs produces additive effects on cognitive and gross motor functioning 3
  • Watch for increased dizziness, somnolence, and coordination problems
  • No dose adjustments required, but counsel patients about enhanced sedation risk

Ropinirole + Zoloft (Sertraline)

Exercise caution with this combination. While no direct pharmacokinetic interaction data exists between these specific drugs, there are theoretical concerns:

  • Ropinirole has serotonergic activity in addition to its dopaminergic effects 4
  • Research demonstrates that ropinirole significantly increases brain serotonin levels 4
  • Combining two serotonergic agents theoretically increases risk of serotonin syndrome, though this is rare with this specific combination
  • Monitor for serotonin syndrome symptoms: agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle rigidity, tremor

Clinical approach:

  • Start with standard doses but educate patient about warning signs
  • No routine dose adjustment needed
  • The combination is commonly used in clinical practice for depression in Parkinson's disease without major issues

Ropinirole + Labetalol

Monitor blood pressure and heart rate carefully. While no direct interaction studies exist for this combination, consider these factors:

  • Ropinirole can cause orthostatic hypotension and dizziness as common side effects
  • Labetalol is a beta-blocker that lowers blood pressure and heart rate
  • Additive hypotensive effects are the primary concern
  • Unlike some beta-blockers (metoprolol, propranolol, carvedilol), labetalol is not primarily metabolized by CYP2D6, reducing concerns about metabolic interactions 5

Clinical monitoring:

  • Check orthostatic vital signs at baseline and after dose changes
  • Counsel patients about fall risk, especially when standing quickly
  • Consider starting with lower doses if initiating either medication
  • Watch for symptomatic hypotension, bradycardia, or syncope

Key Pitfalls to Avoid

  • Don't assume all drug combinations require dose adjustments - Keppra and Lyrica have minimal interaction potential due to their unique pharmacokinetic profiles
  • Don't overlook pharmacodynamic interactions - Even without pharmacokinetic interactions, additive CNS depression (Lyrica) and hypotension (labetalol) require monitoring
  • Don't confuse theoretical risk with clinical significance - The sertraline-ropinirole serotonergic interaction is theoretically possible but rarely problematic in practice

References

2
Research

Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset.

Movement disorders : official journal of the Movement Disorder Society, 2003

Related Questions

Can 5‑HTP be taken safely with Wellbutrin (bupropion)?
Is it appropriate to augment escitalopram 5 mg with bupropion to address lack of focus in an adult, and what dosing regimen should be used?
Which antidepressant has no pharmacokinetic interaction with levetiracetam (Keppra)?
Are there any contraindications or drug interaction concerns when combining duloxetine, lisdexamfetamine (Vyvanse), and buspirone (Buspar)?
What dose of bupropion (Wellbutrin) is equivalent to 20 mg of escitalopram (Lexapro)?
For a 12-year-old patient taking 20 mg of Ritalin (methylphenidate) twice daily, what is the equivalent dose of a long‑acting formulation?
What is the diagnosis and treatment for an adult male presenting with severe right‑sided neck pain, spasm, and markedly limited cervical range of motion without any history of trauma?
What does the 50/50 release mechanism of a 24‑hour methylphenidate capsule mean?
Does the patient exhibit symptoms consistent with a urinary tract infection?
How do chronic allergies affect thyroid function and cortisol levels?
What is the significance of an elevated transferrin level and how should it be evaluated?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.